{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:46:29Z","timestamp":1792079189909,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T00:00:00Z","timestamp":1365206400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00198-013-2343-4","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T14:14:31Z","timestamp":1365171271000},"page":"2571-2579","source":"Crossref","is-referenced-by-count":47,"title":["Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D"],"prefix":"10.1007","volume":"24","author":[{"given":"S. M. H.","family":"Alibhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Z.","family":"Mohamedali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Gulamhusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Panju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Breunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Timilshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Naglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. F.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Warde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Duff Canning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,6]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0090-4295(02)01560-1","volume":"60","author":"MV Meng","year":"2002","unstructured":"Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR (2002) Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology 60:7\u201311, discussion 11\u201312","journal-title":"Urology"},{"key":"2343_CR2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","volume":"294","author":"N Sharifi","year":"2005","unstructured":"Sharifi N, Gulley JL, Dahut WL (2005) Androgen deprivation therapy for prostate cancer. JAMA 294:238\u2013244","journal-title":"JAMA"},{"key":"2343_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2006.06.006","volume":"60","author":"SM Alibhai","year":"2006","unstructured":"Alibhai SM, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201\u2013215","journal-title":"Crit Rev Oncol Hematol"},{"key":"2343_CR4","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1200\/JCO.2010.29.8091","volume":"28","author":"SMH Alibhai","year":"2010","unstructured":"Alibhai SMH, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, Krahn M, Fleshner NE, Warde P, Duff Canning S, Klotz L, Naglie G (2010) Impact of androgen-deprivation therapy on physical function and quality of life in men with non-metastatic prostate cancer. J Clin Oncol 28:5038\u20135045","journal-title":"J Clin Oncol"},{"key":"2343_CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154\u2013164","journal-title":"N Engl J Med"},{"key":"2343_CR6","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2008.20.0923","volume":"27","author":"SM Alibhai","year":"2009","unstructured":"Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF (2009) Impact of androgen deprivation therapy on cardiovascular disease and diabetes. J Clin Oncol 27:3452\u20133458","journal-title":"J Clin Oncol"},{"key":"2343_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","volume":"168","author":"MG Oefelein","year":"2002","unstructured":"Oefelein MG, Ricchiuti V, Conrad W, Resnick MI (2002) Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 168:1005\u20131007","journal-title":"J Urol"},{"key":"2343_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-4295(00)00895-5","volume":"57","author":"BJ Kiratli","year":"2001","unstructured":"Kiratli BJ, Srinivas S, Perkash I, Terris MK (2001) Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer. Urology 57:127\u2013132","journal-title":"Urology"},{"key":"2343_CR9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","volume":"104","author":"VK Wadhwa","year":"2009","unstructured":"Wadhwa VK, Weston R, Mistry R, Parr NJ (2009) Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int 104:800\u2013805","journal-title":"BJU Int"},{"key":"2343_CR10","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","volume":"90","author":"SL Greenspan","year":"2005","unstructured":"Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM (2005) Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endo Metab 90:6410\u20136417","journal-title":"J Clin Endo Metab"},{"key":"2343_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","volume":"175","author":"J Morote","year":"2006","unstructured":"Morote J, Orsola A, Abascal JM, Planas J, Trilla E, Raventos CX, Cecchini L, Encabo G, Reventos J (2006) Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression. J Urol 175:1679\u20131683, discussion 1683","journal-title":"J Urol"},{"key":"2343_CR12","first-page":"2962","volume":"13","author":"GG Duncan","year":"2006","unstructured":"Duncan GG, Corbett T, Lukka H, Warde P, Pickles T (2006) GU radiation oncologists consensus on bone loss from androgen deprivation. Can J Urol 13:2962\u20132966","journal-title":"Can J Urol"},{"key":"2343_CR13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endo Metab 97:1802\u20131822","journal-title":"J Clin Endo Metab"},{"key":"2343_CR14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1634\/theoncologist.2012-0051","volume":"17","author":"M Datta","year":"2012","unstructured":"Datta M, Schwartz GG (2012) Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist 17:1171\u20131179","journal-title":"Oncologist"},{"key":"2343_CR15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-410X.2006.06695.x","volume":"99","author":"J Planas","year":"2007","unstructured":"Planas J, Morote J, Orsola A, Salvador C, Trilla E, Cecchini L, Raventos CX (2007) The relationship between daily calcium intake and bone mineral density in men with prostate cancer. BJU Int 99:812\u2013815, discussion 815\u2013816","journal-title":"BJU Int"},{"key":"2343_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2007.03.026","volume":"70","author":"CW Ryan","year":"2007","unstructured":"Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT (2007) Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy. Urology 70:122\u2013126","journal-title":"Urology"},{"key":"2343_CR17","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1200\/JCO.2010.30.8742","volume":"38","author":"SMH Alibhai","year":"2010","unstructured":"Alibhai SMH, Breunis H, Timilshina N, Marzouk S, Stewart D, Tannock I, Naglie G, Tomlinson G, Fleshner N, Warde P, Duff Canning S (2010) Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 38:5030\u20135037","journal-title":"J Clin Oncol"},{"key":"2343_CR18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1385\/JCD:5:4:435","volume":"5","author":"AA Khan","year":"2002","unstructured":"Khan AA, Brown J, Faulkner K, Kendler D, Lentle B, Leslie W, Miller PD, Nicholson L, Olszynski WP, Watts NB (2002) Standards and guidelines for performing central dual X-ray densitometry from the Canadian Panel of International Society for Clinical Densitometry. Journal of Clinical Densitometry 5:435\u2013445","journal-title":"Journal of Clinical Densitometry"},{"key":"2343_CR19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1359\/jbmr.1997.12.9.1463","volume":"12","author":"SL Hui","year":"1997","unstructured":"Hui SL, Gao S, Zhou XH, Johnston CC Jr, Lu Y, Gluer CC, Grampp S, Genant H (1997) Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res 12:1463\u20131470","journal-title":"J Bone Miner Res"},{"key":"2343_CR20","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","volume":"12","author":"Y Lu","year":"2001","unstructured":"Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward\u2019s triangle. Osteoporos Int 12:438\u2013444","journal-title":"Osteoporos Int"},{"key":"2343_CR21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(11)70389-8","volume":"13","author":"AM Cheung","year":"2012","unstructured":"Cheung AM, Tile L, Cardew S, Pruthi S, Robbins J, Tomlinson G, Kapral MK, Khosla S, Majumdar S, Erlandson M, Scher J, Hu H, Demaras A, Lickley L, Bordeleau L, Elser C, Ingle J, Richardson H, Goss PE (2012) Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial. Lancet Oncol 13:275\u2013284","journal-title":"Lancet Oncol"},{"key":"2343_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43\u201346","journal-title":"Epidemiology"},{"key":"2343_CR23","doi-asserted-by":"crossref","unstructured":"Morote J, Planas J, Mir MC, Raventos CX, Encabo G, Doll A (2011) 33% radius evaluation to assess bone mineral density in prostate cancer patients. World J Urol","DOI":"10.1007\/s00345-010-0630-7"},{"key":"2343_CR24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.juro.2010.04.068","volume":"184","author":"SM Alibhai","year":"2010","unstructured":"Alibhai SM, Duong-Hua M, Cheung AM, Sutradhar R, Warde P, Fleshner NE, Paszat L (2010) Fracture Types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 Men. J Urol 184:918\u2013924","journal-title":"J Urol"},{"key":"2343_CR25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","volume":"163","author":"HW Daniell","year":"2000","unstructured":"Daniell HW, Dunn SR, Ferguson DW, Lomas G, Niazi Z, Stratte PT (2000) Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J Urol 163:181\u2013186","journal-title":"J Urol"},{"key":"2343_CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","volume":"361","author":"MR Smith","year":"2009","unstructured":"Smith MR, Egerdie B, Hernandez Toriz N, Feldman R, Tammela TL, Saad F, Heracek J, Szwedowski M, Ke C, Kupic A, Leder BZ, Goessl C (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745\u2013755","journal-title":"N Engl J Med"},{"key":"2343_CR27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.juro.2010.06.022","volume":"184","author":"MR Smith","year":"2010","unstructured":"Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D, Hancock ML, Steiner MS (2010) Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol 184:1316\u20131321","journal-title":"J Urol"},{"key":"2343_CR28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-155-12-201112200-00005","volume":"155","author":"M Chung","year":"2011","unstructured":"Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011) Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med 155:827\u2013838","journal-title":"Ann Intern Med"},{"key":"2343_CR29","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ajcn\/86.6.1780","volume":"86","author":"HA Bischoff-Ferrari","year":"2007","unstructured":"Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, Specker B, Orav JE, Wong JB, Staehelin HB, O\u2019Reilly E, Kiel DP, Willett WC (2007) Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 86:1780\u20131790","journal-title":"Am J Clin Nutr"},{"key":"2343_CR30","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","volume":"342","author":"MJ Bolland","year":"2011","unstructured":"Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women\u2019s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040","journal-title":"BMJ"},{"key":"2343_CR31","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/jnci\/dji402","volume":"97","author":"X Gao","year":"2005","unstructured":"Gao X, LaValley MP, Tucker KL (2005) Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 97:1768\u20131777","journal-title":"J Natl Cancer Inst"},{"key":"2343_CR32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","volume":"367","author":"HA Bischoff-Ferrari","year":"2012","unstructured":"Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, Flicker L, Wark J, Jackson RD, Cauley JA, Meyer HE, Pfeifer M, Sanders KM, Stahelin HB, Theiler R, Dawson-Hughes B (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40\u201349","journal-title":"N Engl J Med"},{"key":"2343_CR33","doi-asserted-by":"crossref","first-page":"b3692","DOI":"10.1136\/bmj.b3692","volume":"339","author":"HA Bischoff-Ferrari","year":"2009","unstructured":"Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692","journal-title":"BMJ"},{"key":"2343_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00198-008-0650-y","volume":"20","author":"S Adami","year":"2009","unstructured":"Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20:239\u2013244","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-013-2343-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-013-2343-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T22:11:39Z","timestamp":1562883099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-013-2343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,6]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1007\/s00198-013-2343-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,6]]}}}